Not applicableLooking for participantsNCT06715579What this trial is testingCardiac Angiosarcoma International RegistryWho this might be right forCardiac Angiosarcoma Immune Oncology Research Institute 500
Not applicableEnded earlyNCT05729425What this trial is testingEvaluating the Accuracy of Microvessel Ultrasound Imaging for Detecting Extent of Disease in Patients With Angiosarcoma of the SkinWho this might be right forSkin Angiosarcoma Mayo Clinic 1
Not applicableUnknownNCT00900211What this trial is testingTissue Sample Collection From Patients With Soft Tissue Sarcoma of the Arms, Hands, Legs, or Feet Treated on Clinial Trial CRUK-VORTEXWho this might be right forSarcoma The Christie NHS Foundation Trust 400
Testing effectiveness (Phase 2)WithdrawnNCT04607200What this trial is testingAGEN2034 & AGEN1884 in Patients With Recurrent, Inoperable AngiosarcomaWho this might be right forAngiosarcoma Agenus Inc.
Testing effectiveness (Phase 2)Looking for participantsNCT06898970What this trial is testingIntratumoral Vusolimogene Oderparepvec (VO) in Combination With Pembrolizumab for AngiosarcomaWho this might be right forAngiosarcomaAngiosarcoma, Adult Varun Monga, MBBS 18
Testing effectiveness (Phase 2)Study completedNCT00053794What this trial is testingPerifosine in Treating Patients With Metastatic or Locally Advanced Soft Tissue SarcomaWho this might be right forEndometrial CancerSarcoma NCIC Clinical Trials Group 17
Testing effectiveness (Phase 2)Study completedNCT02815995What this trial is testingMulti-Arm Study to Test the Efficacy of Immunotherapeutic Agents in Multiple Sarcoma SubtypesWho this might be right forAdvanced and/or Metastatic Sarcoma M.D. Anderson Cancer Center 57
Testing effectiveness (Phase 2)Active Not RecruitingNCT03921008What this trial is testingInduction Paclitaxel Followed by Concurrent Paclitaxel and Radiation Therapy for Cutaneous AngiosarcomaWho this might be right forCutaneous Angiosarcoma Washington University School of Medicine 20
Early research (Phase 1)Study completedNCT00030784What this trial is testingLiposomal Doxorubicin Plus Ifosfamide in Treating Patients With Advanced or Metastatic Soft Tissue SarcomaWho this might be right forSarcoma European Organisation for Research and Treatment of Cancer - EORTC 28
Testing effectiveness (Phase 2)Ended earlyNCT02212015What this trial is testingEvaluation of Votrient in AngiosarcomaWho this might be right forAngiosarcoma Heidelberg University 26
Testing effectiveness (Phase 2)Looking for participantsNCT06277154What this trial is testingMASCT-I Combined With Doxorubicin and Ifosfamide for First-line Treatment of Advanced Soft Tissue SarcomaWho this might be right forLeiomyosarcomaLiposarcomaSynovial Sarcoma+8 more HRYZ Biotech Co. 148
Early research (Phase 1)Study completedNCT00450736What this trial is testingCelecoxib and Radiation Therapy in Treating Patients With Stage II or Stage III Soft Tissue Sarcoma of the Arm, Hand, Leg, or Foot That Has Been Removed by SurgeryWho this might be right forChildhood Malignant Fibrous Histiocytoma of BoneSarcoma University of Miami 3
Testing effectiveness (Phase 2)Study completedNCT02048722What this trial is testingDaily Oral Regorafenib for Chemotherapy-Refractory, Metastatic and Locally Advanced AngiosarcomaWho this might be right forAdult AngiosarcomaRecurrent Adult Soft Tissue SarcomaStage III Adult Soft Tissue Sarcoma+1 more Northwestern University 31
Testing effectiveness (Phase 2)Study completedNCT00025441What this trial is testingCombination Chemotherapy in Treating Children With Metastatic Rhabdomyosarcoma or Other Malignant Mesenchymal TumorsWho this might be right forOvarian CancerSarcomaSmall Intestine Cancer Societe Internationale d'Oncologie Pediatrique
Testing effectiveness (Phase 2)Ended earlyNCT05826600What this trial is testingOMX-0407 in Patients With Previously Treated Solid Tumours That Can't be Removed SurgicallyWho this might be right forSolid Tumor iOmx Therapeutics AG 68
Testing effectiveness (Phase 2)UnknownNCT00410462What this trial is testingBrostallicin or Doxorubicin as First-Line Therapy in Treating Patients With Relapsed, Refractory, or Metastatic Soft Tissue SarcomaWho this might be right forOvarian CancerSarcomaSmall Intestine Cancer European Organisation for Research and Treatment of Cancer - EORTC 118
Testing effectiveness (Phase 2)Study completedNCT03277924What this trial is testingTrial of Sunitinib and/or Nivolumab Plus Chemotherapy in Advanced Soft Tissue and Bone SarcomasWho this might be right forSoft Tissue SarcomaBone Sarcoma Grupo Espanol de Investigacion en Sarcomas 197
Testing effectiveness (Phase 2)Study completedNCT00041236What this trial is testingExatecan Mesylate in Treating Patients With Advanced Soft Tissue SarcomaWho this might be right forSarcoma European Organisation for Research and Treatment of Cancer - EORTC 39
Testing effectiveness (Phase 2)Active Not RecruitingNCT04339738What this trial is testingTesting the Addition of Nivolumab to Chemotherapy in Treatment of Soft Tissue SarcomaWho this might be right forSkin AngiosarcomaSkin Radiation-Related AngiosarcomaVisceral Angiosarcoma National Cancer Institute (NCI) 90
Early research (Phase 1)Looking for participantsNCT05859074What this trial is testingMQ710 With and Without Pembrolizumab in People With Solid Tumor CancerWho this might be right forCutaneous Squamous Cell CarcinomaSCC - Squamous Cell CarcinomaBasal Cell Carcinoma+16 more Memorial Sloan Kettering Cancer Center 56